Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-15 5:16 pm Unchanged | 2023-05-15 | 13D | OnKure Therapeutics, Inc. OKUR | Novo Holdings A/S | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-05-09 4:31 pm Unchanged | 2023-05-09 | 13D | OnKure Therapeutics, Inc. OKUR | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-09-30 4:45 pm Unchanged | 2022-09-30 | 13D | OnKure Therapeutics, Inc. OKUR | Novo Holdings A/S | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-08-11 4:52 pm Unchanged | 2022-08-11 | 13D | OnKure Therapeutics, Inc. OKUR | Carlyle Group Inc. CG | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-27 3:31 pm Unchanged | 2022-01-27 | 13D | OnKure Therapeutics, Inc. OKUR | Novo Holdings A/S | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-26 4:10 pm Unchanged | 2022-01-26 | 13G | OnKure Therapeutics, Inc. OKUR | Lundbeckfond Invest A/S | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-04-23 08:46 am Unchanged | 2021-04-23 | 13D | OnKure Therapeutics, Inc. OKUR | New Enterprise Associates 15 L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-04-20 4:07 pm Unchanged | 2021-04-20 | 13D | OnKure Therapeutics, Inc. OKUR | Abingworth LLP | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-04-19 2:04 pm Unchanged | 2021-04-19 | 13D | OnKure Therapeutics, Inc. OKUR | RiverVest Venture Fund III L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-04-14 4:43 pm Unchanged | 2021-04-14 | 13D | OnKure Therapeutics, Inc. OKUR | Novo Holdings A/S | 0 0.000% | 0 (Unchanged) | Filing |